Bank Of New York Mellon Corp Repligen Corp Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$162.42 - $220.56 $175 Million - $238 Million	1,080,127 New	1,080,127 $183 Million
Q3 2022 Nov 14, 2022	SELL	$160.42 - $256.21 $3.72 Million - $5.95 Million	-23,204 Reduced 2.3%	983,641 $184 Million
Q2 2022 Aug 15, 2022	BUY	$140.68 - $188.02 $22.2 Million - $29.6 Million	157,633 Added 18.56%	1,006,845 $164 Million
Q1 2022 May 11, 2022	BUY	$161.19 - $257.96 $14.6 Million - $23.4 Million	90,765 Added 11.97%	849,212 $160 Million
Q4 2021 Feb 11, 2022	SELL	$247.59 - $304.47 $13.6 Million - $16.7 Million	-54,779 Reduced 6.74%	758,447 $201 Million
Q3 2021 Nov 12, 2021	SELL	$194.77 - $324.21 $2.45 Million - $4.08 Million	-12,578 Reduced 1.52%	813,226 $235 Million
Q2 2021 Aug 11, 2021	SELL	$165.87 - $220.95 $41.9 Million - $55.8 Million	-252,356 Reduced 23.41%	825,804 $165 Million
Q1 2021 May 13, 2021	BUY	$180.37 - $226.26 $7.53 Million - $9.45 Million	41,759 Added 4.03%	1,078,160 $210 Million
Q4 2020 Feb 09, 2021	BUY	$148.08 - $206.57 $47.4 Million - $66.2 Million	320,301 Added 44.73%	1,036,401 $199 Million
Q3 2020 Nov 12, 2020	BUY	$122.51 - $158.27 $17.4 Million - $22.5 Million	141,962 Added 24.73%	716,100 $106 Million
Q2 2020 Aug 12, 2020	SELL	$94.33 - $140.48 $353,077 - $525,816	-3,743 Reduced 0.65%	574,138 $71 Million
Q1 2020 May 06, 2020	BUY	$84.96 - $109.14 $1.77 Million - $2.27 Million	20,814 Added 3.74%	577,881 $55.8 Million
Q4 2019 Feb 14, 2020	BUY	$73.84 - $93.08 $1.55 Million - $1.95 Million	20,955 Added 3.91%	557,067 $51.5 Million
Q3 2019 Nov 07, 2019	BUY	$76.65 - $95.51 $309,129 - $385,191	4,033 Added 0.76%	536,112 $41.1 Million
Q2 2019 Aug 12, 2019	SELL	$54.2 - $85.95 $4.53 Million - $7.19 Million	-83,667 Reduced 13.59%	532,079 $45.7 Million
Q1 2019 May 14, 2019	BUY	$49.45 - $62.8 $5.64 Million - $7.17 Million	114,148 Added 22.76%	615,746 $36.4 Million
Q4 2018 Feb 11, 2019	SELL	$48.26 - $68.88 $696,247 - $993,731	-14,427 Reduced 2.8%	501,598 $26.5 Million
Q3 2018 Nov 09, 2018	BUY	$46.8 - $58.97 $803,836 - $1.01 Million	17,176 Added 3.44%	516,025 $0
Q2 2018 Aug 06, 2018	BUY	$35.26 - $47.04 $495,085 - $660,488	14,041 Added 2.9%	498,849 $23.5 Million
Q1 2018 May 15, 2018	BUY	$30.92 - $37.27 $519,734 - $626,471	16,809 Added 3.59%	484,808 $17.5 Million
Q4 2017 Feb 09, 2018	BUY	$32.53 - $38.92 $15.2 Million - $18.2 Million	467,999	467,999 $17 Million

Others Institutions Holding RGEN

# of Institutions

488

Shares Held

54.2M

Call Options Held

341K

Put Options Held

235K

Black Rock Inc. New York, NY

7.57M
Shares

$1.09 Billion
0.02% of portfolio
Price T Rowe Associates Inc Baltimore, MD

6.39M
Shares

$923 Million
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

5.04M
Shares

$729 Million
0.01% of portfolio
State Street Corp Boston, MA

1.62M
Shares

$235 Million
0.01% of portfolio
Champlain Investment Partners, LLC Burlington, VT

1.42M
Shares

$205 Million
1.34% of portfolio

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.02B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account